Aortic Aneurysm Market Set for Robust Growth Through 2033
Aortic aneurysm market is experiencing strong momentum and was valued at an estimated USD 5.04 billion in 2025, with forecasts projecting it to reach approximately USD 12.87 billion by 2033, driven by rising prevalence of aortic aneurysms associated with aging populations, hypertension, smoking, and technological advancements in minimally invasive repair solutions. These factors are propelling demand for advanced stent grafts and endovascular interventions that improve patient outcomes while reducing procedural risks.
To delve deeper into this research, kindly explore the following link: https://www.maximizemarketresearch.com/request-sample/105490/
Market Growth Drivers & Opportunity
Aortic aneurysms — abnormal dilations of the aorta that can lead to life-threatening rupture if untreated — are increasingly recognized as a critical cardiovascular condition worldwide, particularly affecting older adults and individuals with cardiovascular risk factors. The global rise in the geriatric population, coupled with lifestyle factors such as smoking and obesity, has significantly elevated the incidence of both abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), thereby fueling the need for effective diagnostic and therapeutic solutions.
Technological evolution has been a key catalyst in market growth, especially through innovations in endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), and more complex procedures such as fenestrated endovascular aneurysm repair (FEVAR). Minimally invasive procedures have gained widespread acceptance due to their reduced perioperative mortality, shorter hospital stays, and faster recovery times compared to traditional open surgical methods. As a result, hospitals and specialized cardiac care centers are increasingly adopting advanced stent graft systems that are tailored for diverse aortic anatomies and offer improved sealing and deployment precision.
Greater emphasis on early screening and diagnosis is another pivotal growth driver. National screening programs for high-risk populations, particularly older men, have boosted early aneurysm detection, which enables timely intervention and significantly lowers the risk of rupture. Improved diagnostic imaging technologies like CT angiography and ultrasound also contribute to higher detection rates and better preoperative planning, enhancing the overall market landscape.
Furthermore, expanding healthcare infrastructure in emerging economies presents fresh opportunities. Enhanced access to cardiovascular care, increased public awareness of aneurysm risks, and rising healthcare expenditure in regions like Asia Pacific are key to broader market penetration. Collaborations among medical device manufacturers, research institutions, and healthcare providers are fostering product innovation and training programs that improve procedural success and expand treatment access across urban and rural healthcare settings.
To explore further details about this research, please go to: https://www.maximizemarketresearch.com/request-sample/105490/
Segmentation Analysis
The aortic aneurysm market’s segmentation reveals how specific categories are shaping demand dynamics across treatment paradigms and clinical settings.
By type, the market is divided into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) segments. The abdominal aortic aneurysm segment dominates market revenue, accounting for the largest share due to its higher incidence rate and well-established screening protocols that drive early intervention. AAA is particularly prevalent among males over the age of 65, and widespread adoption of EVAR as a standard treatment further bolsters this segment’s strength. Meanwhile, thoracic aortic aneurysms are anticipated to register the fastest growth, supported by advancements in TEVAR and expanding treatment eligibility for complex thoracic anatomies.
Within treatment types, the market includes open surgical repair, EVAR, TEVAR, FEVAR, BEVAR, and hybrid procedures. Endovascular modalities such as EVAR and its advanced variants continue to lead due to their minimally invasive nature and favorable patient outcomes. Specifically, EVAR holds the largest treatment share, driven by clinical familiarity and broad use across both abdominal and thoracic aneurysm cases. In contrast, FEVAR and other complex endovascular techniques are growing rapidly as device designs evolve to address branch vessel involvement and challenging anatomical scenarios.
From a product perspective, the aortic stent grafts segment is the primary revenue contributor, reflecting the strong global uptake of these devices in minimally invasive repairs. Innovations such as branched and fenestrated grafts that improve procedural precision and long-term durability continue to enhance this segment’s appeal. Supplementary aortic repair accessory devices — including guidewires, diagnostic catheters, sheaths, and molding balloons — also contribute to market growth as more complex procedures become routine in specialized care environments.
In terms of end use, hospitals dominate the market thanks to their advanced infrastructure, comprehensive diagnostic capabilities, and multidisciplinary teams capable of handling complex aneurysm repairs. However, ambulatory surgical centers are expected to expand rapidly as minimally invasive procedures become more common in outpatient settings due to cost efficiencies and quicker patient recovery.
Leading players in the aortic aneurysm market include Medtronic, W.L. Gore & Associates, Cook, MicroPort Scientific Corporation, Boston Scientific Corporation, Artivion Inc., Cardiatis, Endologix Inc., Braile Biomédica, Lombard Medical, and INVAMED, among others. These companies are focusing on portfolio expansion, strategic collaborations, and geographic reach to stay competitive in a rapidly evolving landscape.
Regional Analysis
North America holds the largest share of the aortic aneurysm market, attributed to its advanced healthcare infrastructure, high disease prevalence, extensive screening programs, and strong adoption of endovascular repair technologies. The United States leads this regional dominance, supported by a mature clinical research ecosystem and favorable reimbursement frameworks that facilitate access to cutting-edge treatments.
Europe represents a significant and stable market, propelled by well-established healthcare systems, rising geriatric populations, and proactive screening initiatives. Countries such as the United Kingdom, Germany, and France are adopting advanced EVAR and TEVAR solutions, while government-led screening programs and rising awareness of aneurysm risks further support regional growth.
The Asia Pacific (APAC) region is projected to witness the fastest growth over the forecast period, reflecting expanding healthcare investment, improving diagnostic access, and rising adoption of endovascular technologies. Urban centers in China, India, Japan, and Southeast Asia are increasingly equipped with advanced cardiovascular intervention capabilities, and growing public awareness of aneurysm screening and treatment contributes to the region’s accelerated market expansion.
Want a comprehensive Market analysis? Check out the summary of the research report: https://www.maximizemarketresearch.com/market-report/global-aortic-aneurysm-market/105490/
Conclusion
The global aortic aneurysm market is poised for substantial growth as healthcare systems worldwide respond to the rising prevalence of cardiovascular diseases, aging populations, and demand for advanced minimally invasive treatment options. Continuous innovation in stent graft technologies, wider screening and early diagnosis initiatives, and expanding treatment access in emerging regions are key factors shaping the market’s future. With hospitals and specialized care centers at the forefront of adoption, and ambulatory surgical centers gaining traction, the market is set to evolve dynamically over the coming decade, delivering improved outcomes for patients and broader opportunities for industry stakeholders.
About Us:
Maximize Market Research is one of the fastest-growing Market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Us:
MAXIMIZE Market RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizeMarketresearch.com
Comments (0)